Filter Search


Healthcare and Medical


Location Summary Deadline
Germany Conclusion Of A Non-exclusive Discount Agreement According To § 130a Abs. 8 Sgb V For The Active Ingredient Estradiol, Valid From 01.05.26 To 30.04.28, With An Optional Extension Of 12 Months. Estradiol 2026-09-12
Germany Conclusion Of A Non-exclusive Discount Agreement According To § 130a Abs. 8 Sgb V For The Active Ingredient Estradiol For The Period 01.05.26 - 30.04.28 (plus Option For 1x12 Months). Estradiol 2026-09-12
Germany Open House Drug Discount Agreements Therapy Allergens For Subcutaneous Immunotherapy, Atc V01aa02 2026-09-12
Germany Conclusion Of A Non-exclusive Discount Agreement According To § 130a Abs. 8 Sgb V For The Active Ingredient Clindamycin, Atc G01aa10 For The Period 01.05.26 - 30.04.28 (plus An Option For 1x12 Months). Clindamycin 2026-09-12
Germany Conclusion Of A Non-exclusive Discount Agreement In Accordance With Section 130a Paragraph 8 Sgb V For The Active Ingredient Glycerol Trinitrate, Atc C05ae01 For The Period May 1, 2026 - April 30, 2028 (plus V. Option 1x12 Months) 2026-09-12
Germany Conclusion Of A Non-exclusive Discount Agreement In Accordance With Section 130a Paragraph 8 Sgb V For The Active Ingredient Megestrol, Atc L02ab01 For The Period May 1, 2026 - April 30, 2028 (plus V. Option 1x12 Months) 2026-09-12
Germany Conclusion Of A Non-exclusive Discount Agreement According To § 130a Abs. 8 Sgb V For The Active Ingredient Enalapril For The Period 01.05.26 - 30.04.28 (plus Option For 1x12 Months). Enalapril 2026-09-12
Germany Open House Drug Discount Agreements Levothyroxine Sodium, Atc H03aa01 2026-09-12
Germany Open House Drug Discount Agreements Clindamycin And Benzoyl Peroxide, Atc D10af54 2026-09-12
Germany Open House Drug Discount Agreements Eptinezumab, Atc N02cd05 2026-09-12
Whats app